Aytu BioPharma, Inc.

AYTU · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income-$14-$16-$17-$109
Dep. & Amort.$5$7$9$10
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$2$6$5
Change in WC-$6-$5-$6-$11
Other Non-Cash$11$10$3$75
Operating Cash Flow-$2-$1-$5-$29
Investing Activities
PP&E Inv.-$0-$0$0$0
Net Acquisitions$0$0-$0-$3
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$2$0-$0-$0
Investing Cash Flow-$3-$0-$0-$3
Financing Activities
Debt Repay.$7-$2-$2-$5
Stock Issued$15$3$16$12
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$6-$3-$4-$5
Financing Cash Flow$15-$1$9$2
Forex Effect$0$0$0$0
Net Chg. in Cash$11-$3$4-$31
Supplemental Information
Beg. Cash$20$23$19$50
End Cash$31$20$23$19
Free Cash Flow-$5-$2-$5-$29